These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 37195768)

  • 1. Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid Neoplasms.
    Xie Z; Chen EC; Mendez LM; Komrokji R; Zeidan AM
    Cancer J; 2023 May-Jun 01; 29(3):130-137. PubMed ID: 37195768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Challenge and Clinical Dilemma: The Long Reach of Clonal Hematopoiesis.
    Osman A; Patel JL
    Clin Chem; 2021 Aug; 67(8):1062-1070. PubMed ID: 34263288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal hematopoiesis and hematological malignancy.
    Dunn WG; McLoughlin MA; Vassiliou GS
    J Clin Invest; 2024 Oct; 134(19):. PubMed ID: 39352393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of clonal hematopoiesis, subtypes and its role in neoplasia and different morbidities.
    Younes IE; Syler L; Hamed A
    Leuk Res; 2023 Jul; 130():107307. PubMed ID: 37186988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Premalignant Clonal Hematopoiesis (Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance).
    Craven KE; Ewalt MD
    Clin Lab Med; 2023 Dec; 43(4):565-576. PubMed ID: 37865503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal hematopoiesis and inflammation: A review of mechanisms and clinical implications.
    Nathan DI; Dougherty M; Bhatta M; Mascarenhas J; Marcellino BK
    Crit Rev Oncol Hematol; 2023 Dec; 192():104187. PubMed ID: 37879493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How low can you go?: Methodologic considerations in clonal hematopoiesis variant calling.
    Beeler JS; Bolton KL
    Leuk Res; 2023 Dec; 135():107419. PubMed ID: 37956474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostics in unclear cytopenia-How and when do we screen for clonal hematopoiesis?].
    Haferlach C; Heuser M
    Inn Med (Heidelb); 2022 Nov; 63(11):1141-1147. PubMed ID: 36121473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEXAS: is it time to reshape the nosology of clonal hematopoiesis?
    Sujobert P; Largeaud L; Jamilloux Y; Heiblig M; Kosmider O
    Expert Rev Hematol; 2023; 16(7):495-499. PubMed ID: 37119011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical manifestations of clonal hematopoiesis: What has SF3B1-mutant MDS taught us?
    Todisco G; Moura PL; Hellström-Lindberg E
    Semin Hematol; 2022 Jul; 59(3):150-155. PubMed ID: 36115692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal Hematopoiesis and risk of Acute Myeloid Leukemia.
    Desai P; Hassane D; Roboz GJ
    Best Pract Res Clin Haematol; 2019 Jun; 32(2):177-185. PubMed ID: 31203999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal hematopoiesis: malignant implications, extrahematologic manifestations, and management.
    Chien KS; DiNardo CD; Garcia-Manero G
    Clin Adv Hematol Oncol; 2024 Sep; 22(7):320-327. PubMed ID: 39110659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How predictive is the finding of clonal hematopoiesis for the development of myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)?
    Steensma DP
    Best Pract Res Clin Haematol; 2021 Dec; 34(4):101327. PubMed ID: 34865699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal hematopoiesis and risk for hematologic malignancy.
    Warren JT; Link DC
    Blood; 2020 Oct; 136(14):1599-1605. PubMed ID: 32736382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline predisposition for clonal hematopoiesis.
    Kubota Y; Viny AD
    Semin Hematol; 2024 Feb; 61(1):61-67. PubMed ID: 38311514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early detection and intervention of clonal hematopoiesis for preventing hematological malignancies.
    Ye B; Sheng Y; Zhang M; Hu Y; Huang H
    Cancer Lett; 2022 Jul; 538():215691. PubMed ID: 35469959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal hematopoiesis: Molecular and clinical implications.
    Kusne Y; Xie Z; Patnaik MM
    Leuk Res; 2022 Feb; 113():106787. PubMed ID: 35091334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasms.
    Chien KS; Ong F; Kim K; Li Z; Kanagal-Shamanna R; DiNardo CD; Takahashi K; Montalban-Bravo G; Hammond D; Sasaki K; Pierce SA; Kantarjian HM; Garcia-Manero G
    Cancer Med; 2024 Mar; 13(5):e7093. PubMed ID: 38497538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How I investigate Clonal cytogenetic abnormalities of undetermined significance.
    Tang G; Medeiros LJ; Wang SA
    Int J Lab Hematol; 2018 Aug; 40(4):385-391. PubMed ID: 29624895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal Hematopoiesis of Indeterminate Potential.
    Heuser M; Thol F; Ganser A
    Dtsch Arztebl Int; 2016 May; 113(18):317-22. PubMed ID: 27215596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.